University of North Carolina, Chapel Hill: Hepatitis trials

The registry lists 16 Hepatitis studies with University of North Carolina, Chapel Hill as lead sponsor. 0 are open to participants now and 4 have results posted.

Phase 1 1Phase 2 1Phase 4 2No phase 12(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Arresting Vertical Transmission of Hepatitis B VirusCompletedNCT03567382Phase 4Results posted
• The Patient-Reported Outcomes Project of HCV-TARGETCompletedNCT02601820Results posted
• Effectiveness of Two Hepatitis B Vaccines in HIV-negative YouthsCompletedNCT00107042Phase 2Results posted
• Comparison of Three Hepatitis B Vaccination Regimens in HIV-Positive YouthCompletedNCT00106964Phase 4Results posted
• Voices From the Black Community: Hepatitis C Research ParticipationCompletedNCT04202081
• Crowdsourcing to Promote HBV and HCV Testing in ChinaCompletedNCT03482388Not applicable
• Pilot Feasibility Study of a Cognitive Behavioral Coping Skills (CBCS) Group Intervention for Hep C Therapy PatientsCompletedNCT03057236Not applicable
• Anticipated and Perceived Benefits Following Hepatitis C TreatmentCompletedNCT03000023
• Evaluation of Serum Chemokines for Patients Undergoing Treatment With Boceprevir.WithdrawnNCT01949077
• The Pathogenesis of Hepatitis C Virus Vertical TransmissionCompletedNCT01921400
• Altered Drug Disposition and Biomarkers for Diagnosis of Chronic Inflammatory Liver DiseaseCompletedNCT01766960Phase 1
• HCV-TARGET- Hepatitis C Therapeutic Registry and Research NetworkCompletedNCT01474811
• Overcoming Psychiatric Barriers to the Treatment of Hepatitis CCompletedNCT00407732Not applicable
• Hepatitis B Vaccine Genetics: A Substudy of ATN 024 and ATN 025CompletedNCT00142740
• Hepatitis C in Clinically Discordant Hemophilic SiblingsCompletedNCT00007371
• Hepatitis Delta Infections in HemophiliacsCompletedNCT00005305